The Galien Forum 2026

November 17, 2026

Warsaw, Polish History Museum

Poland's first platform combining debate on the future of healthcare with the translation and commercialisation of Polish medical innovations.

Dr Hayat Sindi holding up a small diagnostic device.

Special guest Galien Forum 2026

dr Hayat Sindi

Science that changes the world.
Innovations that make a difference.

Dr Hayat Sindi is a globally recognised scientist, inventor and entrepreneur, Global Ambassador for the G20 Health & Development Partnership, UNESCO Goodwill Ambassador for Science, and an advocate for social innovation.

How do scientific discoveries become innovations?

At Galien Forum 2026, Dr Sindi will deliver the keynote address “Science with Purpose”. In this personal and inspiring talk, she will trace her journey from a young girl passionate about science to an internationally respected scientist and global leader.

Drawing on her experience in academia, entrepreneurship, global health, international development, public service, and Saudi Arabia’s Shoura Council, Dr Sindi will share how curiosity, resilience and a commitment to serving others have shaped her belief that purpose drives meaningful innovation and lasting impact. Through stories from her career, she will explore how ideas can become solutions that change lives.

Her achievements have earned recognition from leading international institutions and media organisations. She received the Clinton Global Citizen Award for Leadership in Civil Society, was recognised through President Obama’s “Educate to Innovate” and “Million Minds” initiatives, was named to the BBC 100 Women list, and was recognised by Forbes as one of the most influential women in the Arab world.

The keynote will explore the intersection of science, health, and entrepreneurship, showing how discoveries can become practical innovations, sustainable ventures, and scalable solutions. Dr Sindi will highlight how purpose-driven leadership can address healthcare challenges while advancing economic growth, innovation, and social progress.

Relevant to entrepreneurs, healthcare professionals, researchers, business leaders, policymakers, and innovators, Science with Purpose will offer insights into aligning ambition with purpose, turning challenges into opportunities, and creating meaningful impact across health, business, and society.

UNESCO Goodwill Ambassador
for Science
G20 Health &
Development Partnership
Global Ambassador

Keynote · Galien Forum 2026

Science with Purpose

17 November 2026 09:40 - 10:25 · Warsaw

Join the Forum
Polish History Museum · Warsaw Free admission · Registration required

Galien Forum 2026

Forum Programme

17 November 2026 · Polish History Museum, Warsaw

From Science to System

Discovery is only half of a breakthrough.

Breakthroughs are emerging in new parts of the world, and new capital is financing them. Therapies are changing prognosis faster than the system can keep up. The global map of medicine is being redrawn.

Galien Forum is one day on which the people setting the direction of global science and medicine meet those changing healthcare in Poland. They share one question: where is Poland’s place on this new map?

Keynote-led panel – the Galien Forum format

There are no classic moderated panels at Galien Forum. Each session opens with a short keynote, and invited experts then lead the conversation. We do not ask whether innovation is needed. We ask what happens once it is already here: what challenges it sets before clinicians, the payer and the system as a whole, and which of those questions still have no answer. Every panel ends with three recommendations for decisions in 2027.

Main programme Presentation Hall
Registration
Forum Opening · Keynote-led panel · “A New Map of Medicine” Science is changing its address. The innovation landscape has shifted – is Poland playing by the new rules? Invited experts Prof. dr hab. n. med. Cezary SzczylikKatarzyna KęckaMaciej BagińskiTomasz Hildt

For decades, it was clear where new medicines came from and who funded their development. Today, biotechnology — alongside chips and artificial intelligence — has become a strategic technology. China and the Gulf states are joining the leaders, while global pharmaceutical companies are investing in scientific discoveries at ever earlier stages. Who will shape the direction of medicine over the next decade? Where is value being created in pharmaceutical innovation today? And what place can Poland secure in this new landscape?

Invited experts

  • Prof. dr hab. n. med. Cezary Szczylik

    Oncologist and specialist in clinical oncology, Co-Chair of the Prix Galien Poland Jury.

  • Katarzyna Kęcka

    Undersecretary of State at the Ministry of Health.

  • Maciej Bagiński

    President of the Management Board, Polish Humanitarian Action.

  • Tomasz Hildt

    Regional Director, The Galien Foundation CEE & Middle East, responsible for international cooperation in medical innovation.

Keynote · Dr Hayat Sindi Science with Purpose Science that changes the world. Innovations that make a difference.

How can scientific discoveries become practical innovations, sustainable ventures and solutions that change lives? Dr Hayat Sindi, UNESCO Goodwill Ambassador for Science and Global Ambassador for the G20 Health & Development Partnership, will explore the intersection of science, health and entrepreneurship, showing how purpose-driven leadership can create lasting impact.

Break
Keynote-led panel How will we deliver care in ten years? New healthcare models emerging around the world today Invited experts Prof. dr hab. n. med. Wojciech FendlerProf. dr hab. n. med., dr h.c. mult., FESC Krzysztof J. FilipiakMateusz Oczkowski

Virtual wards in the United Kingdom, hospital-at-home care in the United States, outcomes-based payment in Sweden: models of care that still sound futuristic in Poland are already operating elsewhere. Which of them make sense in the Polish context? What needs to change to put them into practice? How will the roles of hospitals, doctors and patients evolve, and what will healthcare teams need to learn?

Invited experts

  • Prof. dr hab. n. med. Wojciech Fendler

    Head of the Department of Biostatistics and Translational Medicine at the Medical University of Łódź and visiting professor at the Dana-Farber Cancer Institute in Boston. President of the Medical Research Agency, 2024–2026, and Co-Chair of the Prix Galien Poland Jury.

  • Prof. dr hab. n. med., dr h.c. mult., FESC Krzysztof J. Filipiak

    Cardiologist, internist, hypertension specialist and clinical pharmacologist. Director-Rector of the Centre of Postgraduate Medical Education. Member of the Board of Directors of the International Society of Cardiovascular Pharmacotherapy. Member of the Committee of Clinical Sciences and the Committee of Physiological and Pharmacological Sciences of the Polish Academy of Sciences.

  • Mateusz Oczkowski

    Director of the Department of Drug Policy and Pharmacy at the Ministry of Health and Chair of the Economic Commission.

Break
Keynote-led panel · “From Potential to Scale” Potential without borders. Does Polish innovation have to leave the country in order to grow? Invited experts Prof. dr hab. n. farm. Agata Przekora-KuśmierzDr hab. Małgorzata Gałązka-SobotkaAleksandra CzokWojciech Dołkowski

Polish pharmaceutical companies are expanding into global markets, acquiring plants abroad and building international manufacturing networks. What allows them to grow globally while still developing capabilities and investing in Poland? And why is it so difficult to turn the potential of Polish science into innovations that become the foundation of strong, competitive companies? The panel will look at what determines success along this path: from collaboration between science and industry and the financing of development to the role of the state in creating the conditions for commercialising and scaling innovation.

Invited experts

  • Prof. dr hab. n. farm. Agata Przekora-Kuśmierz

    Biotechnologist and expert in tissue engineering and biomaterials. Professor at the Institute of Pharmaceutical Sciences of the John Paul II Catholic University of Lublin.

  • Dr hab. Małgorzata Gałązka-Sobotka

    Rector of Lazarski University, Dean of Lazarski Executive Education and Director of the Institute of Healthcare Management at Lazarski University. Director of the “MBA in Healthcare” programme. From 2015 to 2025, Vice-Chair of the Council of the National Health Fund.

  • Aleksandra Czok

    Director of the Strategic Marketing Department at Adamed Pharma.

  • Wojciech Dołkowski

    Co-founder and President of MEDtube, an international medical education platform.

Break
Keynote-led panel · Keynote: “The First Generation” From innovation to clinical practice. When a breakthrough becomes the standard of care Invited experts Prof. dr hab. n. med. Dorota SandsProf. dr hab. n. med. Urszula DemkowProf. dr hab. n. med. Marcin CzechDr n. biol. Aldona Chmielewska

Until recently, half of all people with cystic fibrosis in Poland did not live to the age of 25, while most children with the most severe form of SMA did not survive to their second birthday without permanent ventilatory support. Today, the first generation of patients receiving new therapies are completing their education, working and planning families. Which clinical questions can medicine still not answer? How do we measure the value of a therapy that transforms a patient’s entire life? And who will guide these patients through adulthood?

Invited experts

  • Prof. dr hab. n. med. Dorota Sands

    Head of the Cystic Fibrosis Treatment Centre in Dziekanów Leśny, specialist in paediatrics and pulmonology, and an expert in the treatment of cystic fibrosis.

  • Prof. dr hab. n. med. Urszula Demkow

    Head of the Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age at the Medical University of Warsaw. Specialist in internal medicine, allergology, immunology and laboratory diagnostics. Deputy Minister of Health from 2024 to 2025.

  • Prof. dr hab. n. med. Marcin Czech

    Professor of medical sciences and economics, Head of the Department of Pharmacoeconomics at the Institute of Mother and Child, President of the Polish Society of Pharmacoeconomics and former Deputy Minister of Health.

  • Dr n. biol. Aldona Chmielewska

    Molecular and cell biologist, coordinator of the rare diseases group at the Association for Good Clinical Practice in Poland (GCPpl).

Networking Lunch
Keynote-led panel · Keynote: “Prognosis Is Shaped Before Diagnosis” Time matters. New opportunities in the diagnosis and treatment of fibrotic lung diseases Invited experts Izabela ObarskaProf. dr hab. n. med. Katarzyna GórskaKatarzyna Romanowska-Próchnicka, MD, PhDJoanna Żuchowska, MD, PhD

Pulmonary fibrosis cannot be reversed. Treatment slows disease progression, but lost lung function cannot be restored, making it essential to start treatment as early as possible. Yet in Poland, the average time to diagnosis of idiopathic pulmonary fibrosis is 12 months, and fewer than half of patients survive five years. Since 1 October 2026, low-dose CT screening for lung cancer has been a guaranteed benefit covered by Poland’s National Health Fund (NFZ), while treatment options are also expanding. Where do we lose the most time, and how can we use these new opportunities to diagnose and treat patients sooner?

Invited experts

  • Izabela Obarska

    Healthcare-system expert in drug policy, reimbursement and access to therapies. From 2016 to 2017 she was Director of the Department of Drug Policy and Pharmacy at the Ministry of Health.

  • Prof. dr hab. n. med. Katarzyna Górska

    Specialist in pulmonary and internal medicine, Deputy Head of the Department of Pulmonology, Internal Medicine, Oncological and Transplant Pulmonology at the National Medical Institute of the Ministry of the Interior and Administration in Warsaw. From 2002 to 2025 she worked clinically, academically and as a teacher at the Medical University of Warsaw. In 2025 she received the title of Professor of Medical and Health Sciences.

  • Katarzyna Romanowska-Próchnicka, MD, PhD

    Specialist in rheumatology and internal medicine, assistant professor at the Medical University of Warsaw and senior assistant at the Department and Outpatient Clinic of Systemic Connective Tissue Diseases at the National Institute of Geriatrics, Rheumatology and Rehabilitation in Warsaw. She diagnoses and treats rheumatic diseases, including systemic connective tissue diseases such as systemic sclerosis and systemic lupus erythematosus.

  • Joanna Żuchowska, MD, PhD

    Radiologist at the 2nd Department of Clinical Radiology, Central Clinical Hospital of the University Clinical Centre at the Medical University of Warsaw. Her work covers diagnostic imaging, including chest CT, which is important in diagnosing lung disease.

Break
Keynote-led panel Who will own healthcare? The future relationship between public and private healthcare Invited experts Dr hab. n. med. Cezary PakulskiMarta Sobczyńska, MD, PhDLidia Niedźwiedzka-OwsiakZbigniew Kowalski

A patient sees a doctor at a public clinic, has tests at a private laboratory and undergoes surgery at a hospital owned by a large healthcare group. Providers are consolidating into ever larger groups, while millions of Poles pay both statutory health insurance contributions and private healthcare subscriptions. Who, in this system, takes responsibility for the patient’s entire course of care? Who will care for an ageing population? And can private healthcare be a profitable business while fulfilling its mission to patients?

Invited experts

  • Dr hab. n. med. Cezary Pakulski

    Anaesthesiologist, intensive care specialist and emergency medicine specialist. Author of the book “System ochrony zdrowia w Polsce. Zdrowiu na ratunek” and co-author of numerous analyses of the healthcare system.

  • Marta Sobczyńska, MD, PhD

    Dean of the Faculty of Medicine at Lazarski University and a paediatrician. She practises in both the public and private sectors. A graduate of an MBA in Healthcare, she has long been involved in developing standards of clinical quality and patient safety.

  • Lidia Niedźwiedzka-Owsiak

    Member of the Management Board and Medical Director of the Great Orchestra of Christmas Charity Foundation, a co-founder who has been with the Foundation since its inception. Doctor honoris causa of the Poznań University of Medical Sciences, recognised for her contribution to the development of healthcare and her work to improve the quality of patient care.

  • Zbigniew Kowalski

    Expert in medical communication and the doctor–patient relationship, lecturer at medical universities and trainer. Author of books and guides for physicians, and a member of the Polish Society of Medical Communication.

Break
Keynote-led panel · “What You Cannot See” Healthcare in the basket. Who is responsible for the patient who buys medicine like a service? Qualifications, quality and responsibility in aesthetic medicine. Invited experts Prof. dr hab. n. med. Piotr RadziszewskiProf. dr hab. n. med. Artur MamcarzMarcin Ambroziak, MD, PhD

A procedure on promotion, a hair transplant, a vitamin drip, a package of tests without a referral — more and more medicine is chosen on a website and added to the basket like any other service. Price and “before and after” photographs often decide the choice. Who should qualify a patient for a procedure? How can a patient check who will perform it? And where is the line between a service and healthcare? The panel will also take account of this year’s reports from the Venus Academy of Aesthetic Medicine.

Invited experts

  • Prof. dr hab. n. med. Piotr Radziszewski

    Head of the Department of General, Oncological and Functional Urology at the Medical University of Warsaw, specialist in urological oncology and da Vinci robotic surgery. Chair of the Venus Academy Jury, President of the Academic Urology Association and a member of the Scientific Council of the Oncology Centre.

  • Prof. dr hab. n. med. Artur Mamcarz

    Specialist in internal medicine and cardiology, Head of the 3rd Department of Internal Medicine and Cardiology at the Medical University of Warsaw. For years he has focused on the modern treatment of cardiovascular disease and on educating doctors and patients in prevention.

  • Marcin Ambroziak, MD, PhD

    Dermatologist with 25 years of experience, co-founder and Medical Director of Klinika Ambroziak. Co-chair of the aesthetic dermatology section of the Polish Dermatological Society and an international trainer in hyaluronic acid products.

Networking and Transfer to the Auditorium
Recognition of Excellence · Auditorium Presentation of the Prix Galien Poland 2026 Medals

For the Greatest Benefit to Humankind: What Defines True Medical Breakthrough Today?

The organiser reserves the right to amend the programme.

GALIEN FORUM 2026

Show you’rejoining us.

Create your own graphic and invite your network to Galien Forum 2026.

Create your graphic
Example participant cards: Adam Kowalski and Marta Malinowska, in Polish and English.

Join Galien Forum 2026. Attendance is free of charge. Registration is required.

Register now →

Strategic Partner of Galien Forum


Knowledge Partners of Galien Forum


Galien Innovation Hub Partners


Honorary Patronage

Two pillars of Galien Forum

Future of Healthcare

Future of Healthcare

Strategic debates on the future of healthcare, new therapies, AI, reimbursement policy and the transformation of care systems.

Galien Innovation Hub

Galien Innovation Hub

Presentations of Polish medical innovations for experts, investors, industry partners and healthcare market leaders.

From Science to Society

From discovery to implementation

Galien Forum is a meeting place for science, medicine, business and capital. We combine strategic debate on the future of healthcare with the presentation of Polish medical innovations to experts, investors and industrial partners actively involved in their development, funding and commercialisation.

We create a space where breakthrough ideas developed at universities, startups and research centres can find their path into clinical practice, the market and patients.

600+

participants

40+

speakers

1 day

of inspiration and debate

Galien Forum panel discussion
Galien Forum participants

Three event stages

01

Presentation Hall

Presentation Hall

The main keynote space for strategic debates on the future of healthcare, the economics of innovation and healthcare system transformation.

02

Forum Hall

Forum Hall

A presentation space for selected Polish healthcare innovations, shown to experts, investors and market partners.

03

Auditorium

Auditorium

The final Forum venue, combined with the Prix Galien Poland distinctions ceremony for the most promising innovations.

Galien Innovation Hub

Polish innovations
on the global stage

A platform connecting Polish medical innovations with international experts, investors and business partners.

  • ✓ Presentations of selected Polish healthcare innovations
  • ✓ 1:1 meetings with investors, experts and industry partners
  • ✓ Access to the international Galien expert network
  • ✓ Support in project development, financing and commercialization
Medical innovations

Networking and media zone

Conversations that continue
beyond the stage

During Galien Forum, the foyer of the Polish History Museum becomes a space for conversations, innovation presentations and professional media communication.

1:1 meetings

Networking

Networking

Coffee breaks, lunch, industry meetings and conversations that begin on stage and continue beyond it.

expert conversations

Interviews

Interviews

A dedicated space for interviews, recordings and expert conversations held during Galien Forum.

innovation zone

Innovation Spots

Innovation Spots

Selected teams presenting Polish healthcare innovations in dedicated showcase spaces.

The Galien Community

The community
that creates innovation

Galien Forum participants include leaders from the medical and innovation communities.

Clinicians and medical opinion leaders

Professors of medical and biomedical sciences

Practicing physicians, department heads and specialists implementing new technologies

Medical and technical universities and research teams

Representatives of the Ministry of Health

Research agencies and institutions: ABM, AOTMiT, NCBR

Patient organizations and healthcare system representatives

Representatives of pharma, biotech, medtech and digital health

Investors, funds and partners supporting innovation commercialization

Join Galien Forum 2026.

The preliminary programme is now available. Register free of charge and join the leaders shaping tomorrow's healthcare.

Feel the atmosphere of Galien Forum

Stay up to date

Receive updates about Prix Galien Poland, Galien Forum and innovations in medicine.

Enter your email address to subscribe to our newsletter.